Long term therapy and outcome of chronic obstructive pulmonary disease with or without co-morbidity: the TORCH study
Submitted: 2 May 2013
Accepted: 2 May 2013
Published: 3 May 2013
Accepted: 2 May 2013
Abstract Views: 882
PDF: 1061
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Marco Candela, Ruggero Pastorelli, Antonio Sacchetta, Mauro Campanini, Leonardo M. Fabbri, Carlo Nozzoli, Management of chronic obstructive pulmonary disease: criteria for an appropriate hospital discharge , Italian Journal of Medicine: Vol. 7 No. 3 (2013)
- Marco Candela, Combination long acting β agonists-inhaled corticosteroids versus dual bronchodilation: a real conflict? , Italian Journal of Medicine: Vol. 9 No. 3 (2015)
- Jadwiga A. Wedzicha, Management of exacerbations of chronic obstructive pulmonary disease with a focus on comorbidities , Italian Journal of Medicine: Vol. 7 No. 2 (2013)
You may also start an advanced similarity search for this article.